Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04655963 · ClinicalTrials.gov registry record · NA

Brain Stimulation for Improving Cognition in Chronic Stroke (NEPTUNE)

A NA study of Chronic Stroke, sponsored by Medical University of South Carolina.

Active
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT04655963 is a NA study of Chronic Stroke that is active but no longer recruiting, run by Medical University of South Carolina. The registered enrollment target is 20 participants, below the 43-participant average among 20 other Chronic Stroke trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04655963, a NA study of Chronic Stroke, is active but no longer recruiting, sponsored by Medical University of South Carolina.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

Few treatments are available for post-stroke rehabilitation. The current study aims to develop a novel, short-term, high-dose repetitive transcranial magnetic stimulation (rTMS) based intervention to improve post-stroke cognitive problems. This study will test the safety as well as changes in cognitive function and brain activation with the administration of an accelerated rTMS protocol in chronic stroke.

Conditions Studied

Interventions

  • DEVICE Repetitive Transcranial Magnetic Stimulation (rTMS)

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2021-01-14
Est. Completion 2026-05-15
Phase NA

What the Registry Record Tells You About NCT04655963

The ClinicalTrials.gov registry entry for NCT04655963 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 43-participant average among 20 other Chronic Stroke trials with a reported enrollment target (53% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Stroke appearing as the primary indexed condition, and to 1 intervention - of which Repetitive Transcranial Magnetic Stimulation (rTMS) is the first listed.

NCT04655963 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT04655963 about?

NCT04655963 is a clinical study titled "Brain Stimulation for Improving Cognition in Chronic Stroke (NEPTUNE)". Few treatments are available for post-stroke rehabilitation. The current study aims to develop a novel, short-term, high-dose repetitive transcranial magnetic stimulation (rTMS) based intervention to improve post-stroke cognitive problems. This study will test the safety as well as changes in cognit...

What is the current status of trial NCT04655963?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2021-01-14. Estimated completion is 2026-05-15.

What conditions does trial NCT04655963 study?

This clinical trial studies the following conditions: Chronic Stroke.

What interventions are being tested in trial NCT04655963?

The interventions under investigation include: Repetitive Transcranial Magnetic Stimulation (rTMS) (DEVICE).

Who is sponsoring clinical trial NCT04655963?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04655963 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.